Monodrug efficacies of sulfonamides in prophylaxis for Pneumocystis carinii pneumonia.
A remarkably high rate of adverse events is associated with the use of trimethoprim-sulfamethoxazole in patients with human immunodeficiency virus type 1 infection. We examined the efficacies of sulfonamides alone in the prevention of Pneumocystis carinii pneumonitis, with the assumption that at lea...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1996
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163239/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8849260/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.4.962 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|